methylprednisolone + hydrocortisone

Methylprednisolone + hydrocortisone is a combination of two synthetic corticosteroids, both of which act as glucocorticoid receptor agonists. These drugs are used for their potent anti-inflammatory and immunosuppressive effects. Methylprednisolone is an intermediate-acting corticosteroid with higher glucocorticoid potency than hydrocortisone, while hydrocortisone is a short-acting corticosteroid that closely mimics endogenous cortisol. Both agents reduce inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability; they also modulate immune responses by inhibiting multiple inflammatory cytokines and mediators. This combination may be considered in clinical scenarios where rapid and broad suppression of inflammation or immune activity is required, though it is not commonly formulated as a fixed-dose product.